bioAffinity Technologies (BIAF) Net Cash Flow (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Net Cash Flow of -$3.4 million for Q1 2026, down 407.34% year-over-year from $1.1 million in Q1 2025, and down 174.84% quarter-over-quarter from -$1.2 million in Q4 2025.
bioAffinity Technologies (BIAF) Net Cash Flow (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Net Cash Flow for 6 consecutive years, with -$3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 407.34% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at $2.7 million (up 232.12% YoY), while the FY2025 annual figure was $5.3 million, up 411.4% from the prior year.
- Net Cash Flow slipped to -$3.4 million in Q1 2026 per BIAF's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $13.3 million in Q3 2022 and bottomed at -$3.8 million in Q3 2023.
- Historically, Net Cash Flow has averaged $115159.7 across 5 years, with a median of -$813630.0 in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 15450.34% in 2025 and fell as far as 449.69% in 2025.
- bioAffinity Technologies' Net Cash Flow stood at -$1.9 million in 2022, then grew by 9.47% to -$1.7 million in 2023, then jumped by 120.66% to $348711.0 in 2024, then sank by 449.69% to -$1.2 million in 2025, then plunged by 174.84% to -$3.4 million in 2026.
- Business Quant data shows BIAF's Net Cash Flow at -$3.4 million in Q1 2026, -$1.2 million in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 718.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.34 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3.57 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 56.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -37.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -3.52 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -50.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -9.27 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -840.60 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | -668,647.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -668,647.00 |
| Jun 30, 2026 | -668,647.00 |
| Mar 31, 2026 | -3.35 Mn |
| Mar 31, 2026 | -3.35 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | 358,129.00 |
| Jun 30, 2025 | 358,129.00 |
| Mar 31, 2025 | -660,585.00 |
| Mar 31, 2025 | -660,585.00 |
| Dec 31, 2024 | 348,711.00 |
| Dec 31, 2024 | 348,711.00 |
| Sep 30, 2024 | -44,731.00 |
| Sep 30, 2024 | -44,731.00 |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -368,405.00 |
| Mar 31, 2024 | -368,405.00 |